Trial 3C-13-4


An Open-Label, Multi-Center, Randomized Phase 1B/2 Study of Pf-05212384 plus 5-Fluorouracil-Leucovorin-Irinotecan (FOLFIRI) versus Bevacizumab plus Folfiri In Metastatic Colorectal Cancer

Type: Treatment
Phase: Phase I/II
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Heinz Josef Lenz, M.D.
Other Trial Staff:  Ramona Lujan, R.N., Taison Tran, D.M., Arthur Alvarez, D.M., Catherine Ticong, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.